BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28649130)

  • 21. Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord.
    Dai WL; Xiong F; Yan B; Cao ZY; Liu WT; Liu JH; Yu BY
    Sci Rep; 2016 Dec; 6():38746. PubMed ID: 28004735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
    Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
    Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
    Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effect of axitinib combined with dopamine and PK-PD modeling in the treatment of human breast cancer xenograft.
    Ma YH; Wang SY; Ren YP; Li J; Guo TJ; Lu W; Zhou TY
    Acta Pharmacol Sin; 2019 Feb; 40(2):243-256. PubMed ID: 29773888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
    Rachner TD; Benad P; Rauner M; Goettsch C; Singh SK; Schoppet M; Hofbauer LC
    J Cell Biochem; 2009 Sep; 108(1):106-16. PubMed ID: 19544400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment.
    Qu D; Wang L; Liu M; Shen S; Li T; Liu Y; Huang M; Liu C; Chen Y; Mo R
    Biomacromolecules; 2017 Apr; 18(4):1268-1280. PubMed ID: 28350158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of synthetic glucocorticoids on breast cancer progression.
    Pang JM; Huang YC; Sun SP; Pan YR; Shen CY; Kao MC; Wang RH; Wang LH; Lin KT
    Steroids; 2020 Dec; 164():108738. PubMed ID: 33065150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Pharmacokinetic/Pharmacodynamic Model of Sunitinib and Dopamine in MCF-7/Adr Xenografts: Linking Cellular Heterogeneity to Tumour Burden.
    Wang S; Zhu X; Han M; Hao F; Lu W; Zhou T
    AAPS J; 2020 Feb; 22(2):45. PubMed ID: 32043246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
    Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
    Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
    Smollich M; Götte M; Fischgräbe J; Macedo LF; Brodie A; Chen S; Radke I; Kiesel L; Wülfing P
    Breast Cancer Res Treat; 2010 Sep; 123(2):345-57. PubMed ID: 19943105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
    Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
    Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of edotecarin in breast carcinoma models.
    Ciomei M; Croci V; Stellari F; Amboldi N; Giavarini R; Pesenti E
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):229-35. PubMed ID: 17089166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
    Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
    Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.